宏源药业：公司的产品生产情况及规划请关注公司的信息披露
Hubei Hongyuan Pharmaceutical Technology Hubei Hongyuan Pharmaceutical Technology (SZ:301246) Zheng Quan Ri Bao Wang·2025-11-19 11:42

Group 1 - The company, Hongyuan Pharmaceutical (301246), responded to investor inquiries on November 19, indicating that details regarding product production and planning should be monitored through the company's information disclosures [1]